维普期刊资源整合服务平台（V6.5）

275篇 您的检索式：作者名="Varo N"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	Soluble CD40L:Risk prediction after acute coronary syndromes 显示文摘	Varo N de Lemos JA Libby P	2003	Circulation2003，108，9：	1
2	Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats显示文摘	Varo N Iraburu MJ Varela M	2000	Hypertension2000，35，6：	1
3	Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells 显示文摘	Schonbeck U Gerdes N Varo N	2002	Circulation2002，106，23：	1
4	C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis 显示文摘	Montero I Orbe J Varo N	2006	J Am Coil Cardiol2006，47，7：	1
5	Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells显示文摘	SCHONBECK U GERDES N VARO N	2002	Circulation2002，106，23：	1
6	Solube CD40L and cardiovascular risk in women显示文摘	VARO N LIBBY P	2001	Circulation2001，104，18：	1
7	Losartan inhibits the post transcriptional synthesis of collagen type Ⅰ and reverses left ventricular fibrosis in spontaneously hypertensive rats显示文摘	Varo N Etayo JC Zalba G	1999	J Hypertens1999，17，：	1
8	Soluble CD40L: risk prediction after acute coronary syndromes 显示文摘	Varo N de Lemos J Libby P	2003	Circulation2003，108，9：	1
9	Usefulness of serum carboxy terminal propep tide of procollagen type Ⅰ in assessment of the cardio reparative ability of antihypertensive treatment in hypertensive patients显示文摘	LOPEZ B QUEREJETA R VARO N etal	2001	Circulation2001，104，2：	1
10	Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease显示文摘	Querejeta R Varo N Lopez B	2000	Circulation2000，101，14：	1
11	Elevated release of sCIMOL from platelets of diabetic patients by thrombin , glucose and advanced gly- cation end products显示文摘	Varo N Libby P Nuzzo R	2005	Diab Vasc Dis Res2005，2，2：	1
12	Soluble CD4oL :risk predic- tion after acute coronary syndromes 显示文摘	Varo N de Lemos JA Libby P	2003	Circulation2003，108，9：	1
13	Transforming growth factor β in hypertensives with cardiorenal damage显示文摘	Laviades C Varo N Diez J	2000	Hypertension2000，36，4：	1
14	C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial ceils:implications for clinical and subclinical atheroselerosis显示文摘	Montero I Orbe J Varo N	2006	J Am Coll Cardiol2006，47，7：	1
15	Soluble CD40L and cardiovascular risk in women 显示文摘	Schonbeck U Varo N Libby P	2001	Circulation2001，104，19：	1
16	Transforming growth factor beta in hypertensives with cardiorenal damage 显示文摘	Laviades C Varo N Diez J	2000	Hypertension2000，36，4：	1
17	Usefulness of serum carboxy terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients显示文摘	Lopez B Querejeta R Varo N	2001	Circulation2001，104，3：	1
18	Transforming growth factor in hypertensives with cardiorenal damage 显示文摘	Laviades C Varo N Diez J	2000	Hyperten- sion2000，36，4：	1
19	Abnormalities of the extracellular degradation of collagen type Ⅰ in essential hypertension 显示文摘	Laviades C Varo N Fernondez J	1998	Circulation1998，98，6：	1
20	Usefulness of serum carboxyterminal propeptide of procollagen type Ⅰ in assessment of the cardioreparatire ability of antihypertensive treatment in hypertensive patients显示文摘	Lopez B Querejeta R Varo N	2001	Circulation2001，104，：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示